Applications of [4-(Methylsulfonyl)Phenyl]Hydrazine Hydrochloride in Industrial Manufacturing

As a direct manufacturer specializing in advanced intermediates, we offer [4-(Methylsulfonyl)Phenyl]Hydrazine Hydrochloride for highly controlled integration into downstream syntheses. The following sections present proven scenarios where this material serves as a key functional building block, supporting detailed industry compliance, process standards, precise recipe adjustments, and concrete finished product categories.

1. Pharmaceutical Intermediate for Antidiabetic Drug API Synthesis

This material plays a crucial role in the synthesis of selected anti-diabetic active pharmaceutical ingredients, supporting hydrazine-based coupling and heterocyclic core building. It enables regioselective transformations in step-growth procedures, allowing control over purity and yield during intermediate formation for final API crystallization.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP, ICH Q7)
• United States Pharmacopeia (USP, relevant monographs)
• European Pharmacopoeia (EP 10.0, general quality chapters)
• China Pharmacopoeia (ChP 2020 Edition, where applicable)

Typical usage ratio

• 0.6–1.2 molar equivalents relative to ketone or aldehyde substrate, adjusted based on target yield and product isolation efficiency.

Downstream process integration

• Charged after initial condensation and purification steps during multi-stage synthesis; introduced under controlled pH for intermediate coupling.

Final product types

• Branded and generic oral antidiabetic APIs (e.g., phenylhydrazone derivatives)
• Bulk pharmaceutical intermediates for further functionalization
• Precursor compounds for finished dosage forms

2. Agrochemical Synthesis of Fungicide and Herbicide Intermediates

Manufacturers employ this hydrazine derivative as a nucleophilic agent for introducing sulfonyl-phenyl functionality in heterocyclic intermediate steps. This approach supports efficient access to structurally defined moieties required for next-generation triazole-based fungicides and sulfonylurea herbicide actives, meeting agri-regulatory standards for residue control and synthetic traceability.

Industry compliance standards

• FAO/WHO Joint Meeting on Pesticide Specifications (JMPS)
• ISO 9001:2015 for agrochemical production plants
• National Registration Procedures (China ICAMA, US EPA 40 CFR, EU PPP Regulation 1107/2009)

Typical usage ratio

• 0.95–1.05 molar equivalents, optimized to minimize residual byproducts in downstream chlorination or cyclization reactions.

Downstream process integration

• Added during initial hydrazone/semicarbazone formation; followed by chlorination, cyclization, or methylation for active intermediate advancement.

Final product types

• Triazole fungicide intermediates (for example, precursors for prothioconazole)
• Sulfonylurea herbicide intermediate compounds
• Stabilized hydrazone derivatives for post-synthesis formulation

3. Intermediate for Specialty Dyes and Pigments Manufacturing

Advanced pigment and azo dye producers use this compound to generate sulfonyl-phenyl substituted hydrazones, enabling high color purity and fade resistance in the final molecular structure. This intermediate facilitates tailored chromophore assembly and consistency in batch production, which aligns with textile and plastic pigment requirements under global regulatory schemes.

Industry compliance standards

• Global Organic Textile Standard (GOTS v6.0, chemical input criteria)
• OEKO-TEX Standard 100 (restricted substance lists for colorants)
• REACH Regulation (EC) No 1907/2006

Typical usage ratio

• 0.8–1.1 molar equivalents for hydrazone formation, depending on target absorbance and purity; ratios adjusted based on dye loading and coupling partner.

Downstream process integration

• Introduced during diazotization and coupling cycles; supports synthesis of azo pigment pre-cursors before final milling, dispersion, or granulation.

Final product types

• Azo dyes for plastic and textile applications
• High-stability pigments for industrial coatings
• Color concentrates for masterbatch operations

4. Fine Chemical Synthesis for Advanced Material Research

Research-driven material manufacturers and contract synthesis labs rely on this highly pure hydrazine salt for constructing functionalized aromatic scaffolds. The material’s specific methylsulfonyl group permits downstream modifications in photostable polymers and customizable monomers prepared under tight process controls aligned with scientific reproducibility benchmarks.

Industry compliance standards

• ISO 17034:2016 (General requirements for reference material producers)
• GLP (Good Laboratory Practice, OECD Principles)
• Internal corporate specifications for advanced material ingredients

Typical usage ratio

• 0.5–1.5 molar equivalents, depending on scaffold target and complexity of final product design; rate informed by desired degree of substitution.

Downstream process integration

• Added as primary hydrazine source during controlled nucleophilic aromatic substitution or stepwise functionalization.

Final product types

• Functionalized research-grade monomers
• Photostable polymer intermediates
• Reference standard compounds for analytical calibration

5. Intermediate for Specialty Pharmaceuticals (Oncology and CNS Research Compounds)

Innovator API manufacturers and medicinal chemistry facilities incorporate this hydrazine derivative during scalable pilot synthesis of substituted hydrazone intermediates intended for oncology and CNS (central nervous system) therapeutic lead candidates. Its specific sulfonyl-phenyl substitution enables introduction of key pharmacophores while meeting stringent downstream QC and traceability expectations.

Industry compliance standards

• ICH Q11: Development and Manufacture of Drug Substances
• EU GMP Guide Part II (API Bulk Manufacturing)
• FDA 21 CFR Parts 210 & 211 (where relevant for US market)

Typical usage ratio

• 1.0–1.3 molar equivalents relative to cyclized substrate, with stoichiometry verified by in-process HPLC monitoring for impurity profile control.

Downstream process integration

• Engaged post core-building in the formation of N-substituted hydrazide intermediates before final salt formation or prodrug development.

Final product types

• Experimental cancer therapeutic intermediates
• Nitrogen heterocycle lead compounds for CNS drug R&D
• Advanced intermediates for milligram to multi-kilogram API synthesis batches